Tecfidera Oral Capsule, Gastro-Resistant 120-240Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Tecfidera: Oral capsule, gastro-resistant (120-240mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

DIMETHYL FUMARATE (dye meth il fue ma rate) helps to decrease the number of multiple sclerosis relapses in people with relapsing-remitting forms of the disease. The medicine does not cure multiple sclerosis

In-Depth Information

Tecfidera 30-Day Starter Pack

NDC: 644060007
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Multiple Sclerosis

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from light
Discard opened bottle after 90 days
Store in original container
Tecfidera 30-Day Starter Pack

Reported Side Effects for Tecfidera 30-Day Starter Pack

Flushing Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Brain Deterioration Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
5.0%*
Severity: MODERATE
Onset: EARLY
Low Lymphocytes Incidence:
5.0%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
8.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
8.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
14.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
18.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More